Cerity Partners’s Fractyl Health GUTS Stock Holding History

Cerity Partners’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Hold	168,500	–	–	﹤0.01%	3164
2026 Q1	$77.1K	Buy	168,500 +5,000	+3%	+$4.61K	﹤0.01%	3054
2025 Q4	$360K	Buy	163,500 +149,934	+1,105%	+$241K	﹤0.01%	2297
2025 Q3	$21.6K	Sell	13,566 -4,920	-27%	-$6.38K	﹤0.01%	2725
2025 Q2	$29.9K	Buy	18,486 +4,759	+35%	+$7.69K	﹤0.01%	2587
2025 Q1	$16.3K	Buy	13,727 +2,727	+25%	+$4.35K	﹤0.01%	2451
2024 Q4	$22.7K	Hold	11,000	–	–	﹤0.01%	2403
2024 Q3	$27.8K	Buy	+11,000	New	+$35.9K	﹤0.01%	2504

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Cerity Partners's GUTS Position: Q2 2026 in Review

Cerity Partners held its Fractyl Health (GUTS) position steady in Q2 2026 at 168,500 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

Cerity Partners first reported a position in GUTS in Q3 2024 and has held it in 8 quarters since. The position peaked at $360K in Q4 2025. 70 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Cerity Partners held 168,500 shares of Fractyl Health worth $134K as of Q2 2026.
Cerity Partners left its Fractyl Health share count unchanged in Q2 2026.
Fractyl Health made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3164 holding.
Cerity Partners first reported a position in Fractyl Health in Q3 2024 and has held it in 8 quarters since.
Cerity Partners's Fractyl Health position peaked at $360K in Q4 2025.
70 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.